416 related articles for article (PubMed ID: 19422054)
1. Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly.
Osiecka KM; Nieznanska H; Skowronek KJ; Karolczak J; Schneider G; Nieznanski K
Proteins; 2009 Nov; 77(2):279-96. PubMed ID: 19422054
[TBL] [Abstract][Full Text] [Related]
2. The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro.
Dong CF; Shi S; Wang XF; An R; Li P; Chen JM; Wang X; Wang GR; Shan B; Zhang BY; Han J; Dong XP
Arch Biochem Biophys; 2008 Feb; 470(1):83-92. PubMed ID: 18037369
[TBL] [Abstract][Full Text] [Related]
3. Prion protein inhibits microtubule assembly by inducing tubulin oligomerization.
Nieznanski K; Podlubnaya ZA; Nieznanska H
Biochem Biophys Res Commun; 2006 Oct; 349(1):391-9. PubMed ID: 16934224
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterisation of novel tubulin-binding motifs located within the C-terminus of TRPV1.
Goswami C; Hucho TB; Hucho F
J Neurochem; 2007 Apr; 101(1):250-62. PubMed ID: 17298389
[TBL] [Abstract][Full Text] [Related]
5. Newly-synthesized beta-tubulin demonstrates domain-specific interactions with the cytosolic chaperonin.
Dobrzynski JK; Sternlicht ML; Farr GW; Sternlicht H
Biochemistry; 1996 Dec; 35(49):15870-82. PubMed ID: 8961952
[TBL] [Abstract][Full Text] [Related]
6. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction between prion protein and tubulin.
Nieznanski K; Nieznanska H; Skowronek KJ; Osiecka KM; Stepkowski D
Biochem Biophys Res Commun; 2005 Aug; 334(2):403-11. PubMed ID: 16004966
[TBL] [Abstract][Full Text] [Related]
8. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein.
Kenward AG; Bartolotti LJ; Burns CS
Biochemistry; 2007 Apr; 46(14):4261-71. PubMed ID: 17371047
[TBL] [Abstract][Full Text] [Related]
9. Prion protein impairs kinesin-driven transport.
Nieznanska H; Dudek E; Zajkowski T; Szczesna E; Kasprzak AA; Nieznanski K
Biochem Biophys Res Commun; 2012 Sep; 425(4):788-93. PubMed ID: 22885185
[TBL] [Abstract][Full Text] [Related]
10. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor.
Hundt C; Peyrin JM; Haïk S; Gauczynski S; Leucht C; Rieger R; Riley ML; Deslys JP; Dormont D; Lasmézas CI; Weiss S
EMBO J; 2001 Nov; 20(21):5876-86. PubMed ID: 11689428
[TBL] [Abstract][Full Text] [Related]
11. The octarepeat region of prion protein, but not the TM1 domain, is important for the antioxidant effect of prion protein.
Malaisé M; Schätzl HM; Bürkle A
Free Radic Biol Med; 2008 Dec; 45(12):1622-30. PubMed ID: 18824094
[TBL] [Abstract][Full Text] [Related]
12. N-terminal stathmin-like peptides bind tubulin and impede microtubule assembly.
Clément MJ; Jourdain I; Lachkar S; Savarin P; Gigant B; Knossow M; Toma F; Sobel A; Curmi PA
Biochemistry; 2005 Nov; 44(44):14616-25. PubMed ID: 16262261
[TBL] [Abstract][Full Text] [Related]
13. PASK (proline-alanine-rich Ste20-related kinase) binds to tubulin and microtubules and is involved in microtubule stabilization.
Tsutsumi T; Kosaka T; Ushiro H; Kimura K; Honda T; Kayahara T; Mizoguchi A
Arch Biochem Biophys; 2008 Sep; 477(2):267-78. PubMed ID: 18675246
[TBL] [Abstract][Full Text] [Related]
14. Anterograde axonal transport of chicken cellular prion protein (PrPc) in vivo requires its N-terminal part.
Butowt R; Davies P; Brown DR
J Neurosci Res; 2007 Sep; 85(12):2567-79. PubMed ID: 17335074
[TBL] [Abstract][Full Text] [Related]
15. Microtubule assembly protects the region 28-38 of the beta-tubulin subunit.
Chène P; Mazarguil H; Wright M
Cell Motil Cytoskeleton; 1992; 22(1):25-37. PubMed ID: 1581978
[TBL] [Abstract][Full Text] [Related]
16. Myosin light chain kinase (210 kDa) is a potential cytoskeleton integrator through its unique N-terminal domain.
Kudryashov DS; Stepanova OV; Vilitkevich EL; Nikonenko TA; Nadezhdina ES; Shanina NA; Lukas TJ; Van Eldik LJ; Watterson DM; Shirinsky VP
Exp Cell Res; 2004 Aug; 298(2):407-17. PubMed ID: 15265689
[TBL] [Abstract][Full Text] [Related]
17. A human prion protein peptide (PrP(59-91)) protects against copper neurotoxicity.
Chacón MA; Barría MI; Lorca R; Huidobro-Toro JP; Inestrosa NC
Mol Psychiatry; 2003 Oct; 8(10):853-62, 835. PubMed ID: 14515136
[TBL] [Abstract][Full Text] [Related]
18. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus.
Li R; Liu T; Wong BS; Pan T; Morillas M; Swietnicki W; O'Rourke K; Gambetti P; Surewicz WK; Sy MS
J Mol Biol; 2000 Aug; 301(3):567-73. PubMed ID: 10966770
[TBL] [Abstract][Full Text] [Related]
19. Folding, stability and polymerization properties of FtsZ chimeras with inserted tubulin loops involved in the interaction with the cytosolic chaperonin CCT and in microtubule formation.
Bertrand S; Barthelemy I; Oliva MA; Carrascosa JL; Andreu JM; Valpuesta JM
J Mol Biol; 2005 Feb; 346(1):319-30. PubMed ID: 15663947
[TBL] [Abstract][Full Text] [Related]
20. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges.
González-Iglesias R; Pajares MA; Ocal C; Espinosa JC; Oesch B; Gasset M
J Mol Biol; 2002 May; 319(2):527-40. PubMed ID: 12051926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
